Author

Shelly Simpson

Institutions: University of South Florida, Tampa General Hospital, Alliance for International Medical Action, Leidos Biomedical Research Inc. (United States)

Observed institutions: University of South Florida, Tampa General Hospital, Alliance for International Medical Action, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc. (United States)

ORCID: 0009-0009-6140-4491

Observed ORCID: 0009-0009-6140-4491

OpenAlex ID: A5056906656

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31

Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases

2024 · Aurélie Wiedemann, Edouard Lhomme, et al. · Nature Communications · 23

Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults

2023 · Andrew W Lee, Ken Liu, et al. · Clinical Infectious Diseases · 19

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

2023 · Samuel M Brown, Christina E Barkauskas, et al. · The Lancet Respiratory Medicine · 19

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

2021 · Moses Badio, Edouard Lhomme, et al. · Trials · 18

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial

2024 · Simon Valayer, Marie Alexandre, et al. · Emerging Microbes & Infections · 4

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4

Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies

2021 · Laura A. McNay, Gretchen Arnoczy, et al. · Vaccine · 3

Works count: 10

Citation count: 195

H-index: 7

I10-index: 7